Press enter to activate the dialog and use the tab key to navigate through the options.

AtriCure, Inc. Company Logo
  1. Top Workplaces
  2. AtriCure, Inc.

AtriCure, Inc.

AtriCure is a medical device company providing innovative solutions for the treatment of atrial fibrillation (Afib). Afib affects more than 33 million people worldwide. Afib is a serious cardiac condition that increases the risk of stroke, slows down blood flow, and can lead to other serious heart conditions. AtriCure has the first and only surgical device approved to treat Afib in the U.S. In addition, we pioneered the AtriClip®, a left atrial appendage (LAA) occlusion device that is the most widely implanted device for LAA management. We also market a device for intrathoracic pain management. Through our commitment to product innovation and education grounded in clinical science, we’re working to reduce the global Afib epidemic and living our core values focused on Patients, People, and Partners.... Read more

Purpose

The advancement of medical treatments in order to provide a service to humanity... Read more

Vision

To continue a leadership position in the treatment of Atrial Fibrillation... Read more

Mission

We are passionately focused on reducing the global Afib epidemic and healing the lives of those affected.... Read more

Additional Culture Details

Our corporate integrity, honesty, and transparency are unwavering.... Read more

Values

Patients
Our first responsibility is to put patients first. We lead rigorous clinical science to determine the safest, most effective approaches and treatments. Our commitment to education generates consistent, predictable practices and standards of care. We undertake relentless innovation to reveal new ideas that improve the experience of providers and supports the care they deliver to each patient.

Headquarters

Mason, OH

Employees

837 US Employees

Industry

Life-sciences - Other

Recent Awards

Company Snapshots

IMG_1291.jpg
IMG_3659.jpg
IMG_0954.jpg
00100lPORTRAIT_00100_BURST20190727180805979_COVER.jpg